Pfizer launches clinical trial of new crown vaccine in children under 12 years old

According to foreign media reports such as NEXSTAR and CNBC, Pfizer recently announced that it has begun clinical trials of the new crown vaccine for children under 12 years of age .

The vaccine is Pfizer Inc.

This new coronavirus vaccine is a messenger ribonucleic acid (mRNA) vaccine that can target the spike protein of the new coronavirus.

Dr.

Pfizer and BioNTech plan to recruit 144 children to participate in the Phase I/II trial to initially test the safety of two doses of the vaccine at three different doses (10, 20, and 30 micrograms).

Pfizer spokesperson Sharon Castillo (Sharon Castillo) said that researchers are currently conducting a phase III clinical trial of the vaccine on minors between 12 and 15 years old, with approximately 2,259 children being tested.

It is not clear when the COVID-19 vaccine will be widely used in children.

references

"Pfizer begins testing vaccine in children under age 12"

"Pfizer, BioNTech launch COVID-19 vaccine trial in kids under 12"

"Pfizer says its Covid vaccine trial for kids ages 12 to 15 is fully enrolled"